Literature DB >> 21839520

Retinal crystals in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo1, Irene Leung, Mina Chung, Ute E K Wolf-Schnurrbusch, Alfredo Dubra, David R Williams, Traci Clemons, Daniel Pauleikhoff, Alan C Bird, Tunde Peto.   

Abstract

PURPOSE: To characterize the phenotype and investigate the associations of intraretinal crystalline deposits in a large cohort with type 2 idiopathic macular telangiectasia (MacTel).
DESIGN: Case-control study. PARTICIPANTS: Patients with and without retinal crystals from the Macular Telangiectasia Project, an international multicenter prospective study of type 2 MacTel.
METHODS: Grading of stereoscopic 30-degree color fundus (CF), confocal blue light reflectance (CBR), red-free (RF), and infrared (IR) images was performed according to the MacTel Natural History Study protocol and staged using the classification system devised by Gass and Blodi. Spectral domain-optical coherence tomography (SD-OCT) and adaptive optics imaging were used for a finer analysis of the phenotype. Associations between crystals and other characteristics of the disease, as well as potential risk factors, were investigated. MAIN OUTCOME MEASURES: Presence of crystals, fundus signs of MacTel, clinical characteristics, and presence of potential risk factors of MacTel.
RESULTS: Of 443 probands enrolled in the MacTel study, 203 (46%) had crystalline deposits present; 60% of the cases were bilateral at baseline. Eyes with crystals had a mean letter score of 70.7 (standard deviation [SD] = 15.9), whereas those without crystals had a mean letter score of 66.5 (SD = 15.5, P < 0.001). Crystals were present at all stages of the disease and showed high reflectivity within a wide wavelength range. They were located at the anterior surface of the nerve fiber layer, arranged along the nerve fibers, within an annular area centered on the fovea. Significant associations of crystalline deposits were found with a loss of retinal transparency, macular pigment optical density (MPOD) loss, fluorescein leakage, retinal thickness, and a break in the inner segment/outer segment junction line. Associations with environmental risk factors were not found.
CONCLUSIONS: Intraretinal crystals are a frequent phenomenon associated with type 2 MacTel. They may appear at all stages and aid in the early diagnosis of the disease. Their morphology further implicates Müller cells in the pathogenesis of the disease. Insight into their physical and chemical properties may provide clues to the metabolic pathways involved in the pathogenesis of the disease. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839520      PMCID: PMC3433242          DOI: 10.1016/j.ophtha.2011.05.022

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  21 in total

1.  The Wisconsin age-related maculopathy grading system.

Authors:  R Klein; M D Davis; Y L Magli; P Segal; B E Klein; L Hubbard
Journal:  Ophthalmology       Date:  1991-07       Impact factor: 12.079

2.  Intraretinal crystalline deposits in neovascular age-related macular degeneration.

Authors:  Luiz H Lima; K Bailey Freund; James M Klancnik; Richard F Spaide
Journal:  Retina       Date:  2010-04       Impact factor: 4.256

3.  Superficial retinal refractile deposits in juxtafoveal telangiectasis.

Authors:  J Moisseiev; H Lewis; E Bartov; S L Fine; R P Murphy
Journal:  Am J Ophthalmol       Date:  1990-05-15       Impact factor: 5.258

4.  Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

5.  Idiopathic macular telangiectasia.

Authors:  Lawrence A Yannuzzi; Anne M C Bardal; K Bailey Freund; Kuan-Jen Chen; Chiara M Eandi; Barbara Blodi
Journal:  Arch Ophthalmol       Date:  2006-04

Review 6.  Crystalline retinopathies.

Authors:  Kimberly Drenser; David Sarraf; Atul Jain; Kent W Small
Journal:  Surv Ophthalmol       Date:  2006 Nov-Dec       Impact factor: 6.048

7.  Idiopathic juxtafoveolar retinal telangiectasis.

Authors:  J D Gass; R T Oyakawa
Journal:  Arch Ophthalmol       Date:  1982-05

8.  Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.

Authors:  Traci E Clemons; Marc C Gillies; Emily Y Chew; Alan C Bird; Tunde Peto; Maria J Figueroa; Molly W Harrington
Journal:  Ophthalmic Epidemiol       Date:  2010 Jan-Feb       Impact factor: 1.648

9.  First-order design of off-axis reflective ophthalmic adaptive optics systems using afocal telescopes.

Authors:  Armando Gómez-Vieyra; Alfredo Dubra; Daniel Malacara-Hernández; David R Williams
Journal:  Opt Express       Date:  2009-10-12       Impact factor: 3.894

10.  In-vivo imaging of retinal nerve fiber layer vasculature: imaging histology comparison.

Authors:  Drew Scoles; Daniel C Gray; Jennifer J Hunter; Robert Wolfe; Bernard P Gee; Ying Geng; Benjamin D Masella; Richard T Libby; Stephen Russell; David R Williams; William H Merigan
Journal:  BMC Ophthalmol       Date:  2009-08-23       Impact factor: 2.209

View more
  12 in total

1.  The Onion Sign in Neovascular Age-Related Macular Degeneration Represents Cholesterol Crystals.

Authors:  Claudine E Pang; Jeffrey D Messinger; Emma C Zanzottera; K Bailey Freund; Christine A Curcio
Journal:  Ophthalmology       Date:  2015-08-19       Impact factor: 12.079

2.  CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.

Authors:  Tunde Peto; Tjebo F C Heeren; Traci E Clemons; Ferenc B Sallo; Irene Leung; Emily Y Chew; Alan C Bird
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

Review 3.  Adaptive optics retinal imaging--clinical opportunities and challenges.

Authors:  Joseph Carroll; David B Kay; Drew Scoles; Alfredo Dubra; Marco Lombardo
Journal:  Curr Eye Res       Date:  2013-04-26       Impact factor: 2.424

4.  [Morphological characteristics in macular telangiectasia type 2].

Authors:  P Charbel Issa; T F C Heeren; E Krüger; M Zeimer; D Pauleikhoff; F G Holz
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

5.  ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Authors:  Ferenc B Sallo; Irene Leung; Meike Zeimer; Traci E Clemons; Adam M Dubis; Marcus Fruttiger; Daniel Pauleikhoff; Emily Y Chew; Catherine Egan; Tunde Peto; Alan C Bird
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

Review 6.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

7.  SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2.

Authors:  Qinqin Zhang; Ruikang K Wang; Chieh-Li Chen; Andrew D Legarreta; Mary K Durbin; Lin An; Utkarsh Sharma; Paul F Stetson; John E Legarreta; Luiz Roisman; Giovanni Gregori; Philip J Rosenfeld
Journal:  Retina       Date:  2015-11       Impact factor: 4.256

8.  Conditional Müllercell ablation causes independent neuronal and vascular pathologies in a novel transgenic model.

Authors:  Weiyong Shen; Marcus Fruttiger; Ling Zhu; Sook H Chung; Nigel L Barnett; Joshua K Kirk; SoRa Lee; Nathan J Coorey; Murray Killingsworth; Larry S Sherman; Mark C Gillies
Journal:  J Neurosci       Date:  2012-11-07       Impact factor: 6.167

9.  Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.

Authors:  Lydia Sauer; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Ophthalmol Retina       Date:  2017-12-08

10.  Relevance of Multicolor Imaging in Type 2 Macular Telangiectasia.

Authors:  Ramesh Venkatesh; Arpitha Pereira; Bharathi Bavaharan; Kushagra Jain; Aditya Aseem; Sajjan Sangai; Naresh Kumar Yadav
Journal:  J Curr Ophthalmol       Date:  2020-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.